Hims and Mounjaro: Tirzepatide, Branded vs Compounded

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This Education Hub article covers GLP-1 therapies, weight management protocols, and the genetic variables shaping metabolic decisions. Browse all Peptides & GLP-1 education

This is an independent editorial review. PlexusDx has no commercial relationship with Hims or its parent company, and no affiliate links or compensation are involved.

Mounjaro is a brand name, tirzepatide is the molecule beneath it, and the two are easy to conflate when searching for telehealth options. This review draws the distinction clearly and explains where a subscription brand like Hims fits the branded-versus-compounded tirzepatide picture — balanced editorial framing, not a buying recommendation, as of April 2026.

Mounjaro, tirzepatide, and what the names mean

Tirzepatide is a GIP/GLP-1 dual agonist, distinct from single-target GLP-1 receptor agonists such as semaglutide, liraglutide, and dulaglutide. Mounjaro is one FDA-approved brand of tirzepatide. Understanding that the brand and the molecule are not interchangeable is the starting point for reading any telehealth program's offering accurately.

How a telehealth brand fits the tirzepatide picture

Hims (Hims & Hers Health) operates as subscription telehealth: a licensed provider evaluates the patient virtually, then writes a prescription that routes to either a retail pharmacy for FDA-approved brand products or a 503A compounding pharmacy for compounded semaglutide or tirzepatide. Whether a program provides a branded product or a compounded preparation is shown at intake — check Hims's official website for the current arrangement.

The workflow behind a tirzepatide prescription

Telehealth GLP-1 programs share a common path: an intake covering weight, medical history, and medications; a licensed clinician's review and, if eligible, a prescription; fulfillment through a retail or compounding pharmacy; and follow-up for titration and side-effect management. Provider type, pharmacy partner, and subscription tier vary from one brand to the next, so the tirzepatide experience on one platform will not match another even when the underlying molecule is identical.

What SURMOUNT established about tirzepatide

Tirzepatide's evidence base comes largely from the SURMOUNT program (tirzepatide for weight management, The New England Journal of Medicine, 2022) and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024); the semaglutide comparison point is STEP (NEJM 2021). Trial populations and endpoints differ, and individual outcomes vary. This review provides no dosing figures or injection technique.

The genetic terrain tirzepatide acts on

A tirzepatide decision still leaves the underlying biology unmapped. TCF7L2, a transcription factor tied to glucose homeostasis and GLP-1 secretion, sits with GLP1R (the GLP-1 receptor gene the compound engages), FTO (fat-mass and obesity-associated), and MC4R (a melanocortin receptor central to satiety). These pathway-level variants do not predict response to tirzepatide; they describe the metabolic terrain a clinician prescribes into.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Before any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including TCF7L2, FTO, and MC4R variants that shape baseline glucose-handling and appetite biology. That is the test before you invest logic: informed conversation over guesswork.

Not affiliated: PlexusDx has no affiliation with Hims and no commercial relationship with any company reviewed here.

Related reading on PlexusDx: Mounjaro Alternatives, Mounjaro Review, Alternatives For Mounjaro, Cheap Mounjaro.

Compare the PlexusDx approach: the Weight Management Protocols pair semaglutide and tirzepatide with genetic context, or take the Precision Peptide Genetic Test to map your GLP-1 pathway first.

Frequently Asked Questions

Is Mounjaro the same as tirzepatide?

Mounjaro is one FDA-approved brand name for the molecule tirzepatide, a GIP/GLP-1 dual agonist. The brand and the molecule are related but not synonymous, and a telehealth program may involve branded tirzepatide, a 503A-compounded version, or neither. Confirm which applies on the brand's own website before assuming.

Does Hims provide Mounjaro specifically?

Whether any telehealth brand offers a specific branded product is a program-level detail shown at intake and subject to change. Rather than assume Mounjaro itself is available, verify the current compound and sourcing — branded retail versus 503A-compounded tirzepatide — directly on Hims's own website.

How does the Precision Peptide Genetic Test relate to tirzepatide?

It does not predict response to tirzepatide or any specific compound. It reads pathway-level variants in TCF7L2 and FTO, and MC4R that describe your baseline glucose-handling and appetite biology — upstream context that applies no matter which program prescribes or which compound is dispensed.

Where can I confirm current pricing?

Only on the brand's own website, which publishes fees that change over time. Telehealth GLP-1 totals in this market run roughly $200 to $700+ per month as of April 2026 depending on compound, tier, and dispensing pathway. Treat third-party figures as unverified until you check the source.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Disclaimer: This article is educational. PlexusDx is not affiliated with Hims and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols; this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.